Biodefense: Trends and Challenges in Combating Biological Warfare Agents

Overview

Journal Virulence

Specialty Microbiology

Date 2013 Nov 19

PMID 24241242

Citations 2

Authors

George P Tegos

Affiliations

Soon will be listed here.

Citing Articles

Blueprints for Biosensors: Design, Limitations, and Applications.

Carpenter A, Paulsen I, Williams T Genes (Basel). 2018; 9(8).

PMID: 30050028 PMC: 6115959. DOI: 10.3390/genes9080375.

Photoantimicrobials-are we afraid of the light?.

Wainwright M, Maisch T, Nonell S, Plaetzer K, Almeida A, Tegos G Lancet Infect Dis. 2016; 17(2):e49-e55.

PMID: 27884621 PMC: 5280084. DOI: 10.1016/S1473-3099(16)30268-7.

References

Thomas R . Particle size and pathogenicity in the respiratory tract. Virulence. 2013; 4(8):847-58. PMC: 3925716. DOI: 10.4161/viru.27172. View

Metzgar D, Sampath R, Rounds M, Ecker D . The value and validation of broad spectrum biosensors for diagnosis and biodefense. Virulence. 2013; 4(8):752-8. PMC: 3925709. DOI: 10.4161/viru.26652. View

Virgin H, Todd J . Metagenomics and personalized medicine. Cell. 2011; 147(1):44-56. PMC: 4618802. DOI: 10.1016/j.cell.2011.09.009. View

Glasner J, Plunkett 3rd G, Anderson B, Baumler D, Biehl B, Burland V . Enteropathogen Resource Integration Center (ERIC): bioinformatics support for research on biodefense-relevant enterobacteria. Nucleic Acids Res. 2007; 36(Database issue):D519-23. PMC: 2238966. DOI: 10.1093/nar/gkm973. View

Wiersinga W, Currie B, Peacock S . Melioidosis. N Engl J Med. 2012; 367(11):1035-44. DOI: 10.1056/NEJMra1204699. View

Harris J, Micheva-Viteva S, Li N, Hong-Geller E . Small RNA-mediated regulation of host-pathogen interactions. Virulence. 2013; 4(8):785-95. PMC: 3925712. DOI: 10.4161/viru.26119. View

Rholl D, Trunck L, Schweizer H . In vivo Himar1 transposon mutagenesis of Burkholderia pseudomallei. Appl Environ Microbiol. 2008; 74(24):7529-35. PMC: 2607188. DOI: 10.1128/AEM.01973-08. View

Matheny J, Mair M, Smith B . Cost/success projections for US biodefense countermeasure development. Nat Biotechnol. 2008; 26(9):981-3. DOI: 10.1038/nbt0908-981. View

Wright P, Richter A, Papenfort K, Mann M, Vogel J, Hess W . Comparative genomics boosts target prediction for bacterial small RNAs. Proc Natl Acad Sci U S A. 2013; 110(37):E3487-96. PMC: 3773804. DOI: 10.1073/pnas.1303248110. View

10.

Vatansever F, Ferraresi C, de Sousa M, Yin R, Rineh A, Sharma S . Can biowarfare agents be defeated with light?. Virulence. 2013; 4(8):796-825. PMC: 3925713. DOI: 10.4161/viru.26475. View

11.

van Hoek M . Biofilms: an advancement in our understanding of Francisella species. Virulence. 2013; 4(8):833-46. PMC: 3925715. DOI: 10.4161/viru.27023. View

12.

Greene J, Plunkett 3rd G, Burland V, Glasner J, Cabot E, Anderson B . A new asset for pathogen informatics--the Enteropathogen Resource Integration Center (ERIC), an NIAID Bioinformatics Resource Center for Biodefense and Emerging/Re-emerging Infectious Disease. Adv Exp Med Biol. 2007; 603:28-42. DOI: 10.1007/978-0-387-72124-8_4. View

13.

Skyberg J . Immunotherapy for tularemia. Virulence. 2013; 4(8):859-70. PMC: 3925717. DOI: 10.4161/viru.25454. View

14.

Moreau G, Mann B . Adherence and uptake of Francisella into host cells. Virulence. 2013; 4(8):826-32. PMC: 3925714. DOI: 10.4161/viru.25629. View

15.

Stundick M, Albrecht M, Houchens C, Smith A, Dreier T, Larsen J . Animal models for Francisella tularensis and Burkholderia species: scientific and regulatory gaps toward approval of antibiotics under the FDA Animal Rule. Vet Pathol. 2013; 50(5):877-92. DOI: 10.1177/0300985813486812. View

16.

Drake R, Deng Y, Schwegler E, Gravenstein S . Proteomics for biodefense applications: progress and opportunities. Expert Rev Proteomics. 2005; 2(2):203-13. PMC: 7105753. DOI: 10.1586/14789450.2.2.203. View

17.

Agren J, Hamidjaja R, Hansen T, Ruuls R, Thierry S, Vigre H . In silico and in vitro evaluation of PCR-based assays for the detection of Bacillus anthracis chromosomal signature sequences. Virulence. 2013; 4(8):671-85. PMC: 3925699. DOI: 10.4161/viru.26288. View

18.

Levy B, Sidel V . Adverse health consequences of US Government responses to the 2001 terrorist attacks. Lancet. 2011; 378(9794):944-52. DOI: 10.1016/S0140-6736(11)60970-7. View

19.

Tegos G, Hamblin M . Disruptive innovations: new anti-infectives in the age of resistance. Curr Opin Pharmacol. 2013; 13(5):673-7. PMC: 3831660. DOI: 10.1016/j.coph.2013.08.012. View

20.

Walsh M, Dodd J, Hautbergue G . Ribosome-inactivating proteins: potent poisons and molecular tools. Virulence. 2013; 4(8):774-84. PMC: 3925711. DOI: 10.4161/viru.26399. View